SOUTH
SAN FRANCISCO, Calif. and VANCOUVER, BC,
April 9,
2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the
"Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company
focused on developing novel therapies for the treatment of prostate
cancer, today announced that the Company will be presenting at
the 2024 Bloom Burton & Co. Healthcare Investor Conference
on Tuesday, April 16, 2024 at 2:30 p.m. ET in
Toronto, Canada.
David. R. Parkinson, President, and Chief Executive
Officer; Peter Virsik, Chief Operating Officer; and David
S. Wood, Chief Financial Officer, will host and participate in
one-on-one meetings.
A live webcast of the presentation can be accessed in the
Investors/Events & Presentations section of ESSA's website
at www.essapharma.com. Following the event, the webcast will
be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on
developing novel and proprietary therapies for the treatment of
patients with prostate cancer. For more information, please
visit www.essapharma.com, and follow us
on Twitter and LinkedIn.
Contacts
ESSA Pharma, Inc.
Peter Virsik, Chief Operating
Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-2024-bloom-burton--co-healthcare-investor-conference-302111122.html
SOURCE ESSA Pharma Inc